KIM
BIO icon

Kestra Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Kestra Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7
Closed -$2.3K – 948
2024
Q4 		$2.3K Buy
+7
New +$2.38K ﹤0.01% 1017

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kestra Investment Management's BIO Position: Q1 2025 in Review

Kestra Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 7 shares — an estimated $2.3K sold.

Kestra Investment Management first reported a position in BIO in Q4 2024 and held it in 1 quarter. The position peaked at $2.3K in Q4 2024. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Kestra Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Kestra Investment Management sold 7 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $2.3K.
  • Kestra Investment Management first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and held it in 1 quarter.
  • Kestra Investment Management's Bio-Rad Laboratories Class A position peaked at $2.3K in Q4 2024.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Kestra Investment Management's 13F filing for Q1 2025, filed 16 May 2025.